Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CD74, also known as the invariant chain (Ii), is a type II transmembrane glycoprotein that plays a central role in antigen presentation and immune regulation. It acts as a chaperone for MHC class II molecules, guiding them through the endoplasmic reticulum and preventing premature peptide binding. CD74 also functions as a receptor for macrophage migration inhibitory factor (MIF), mediating downstream signaling involved in inflammatory responses and cell proliferation. Overexpression of CD74 is observed in various lymphomas and cancers, making it a target for immuno-oncology therapies.
Antibody-drug conjugate targeting CD74
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CD74 molecule (CD74).